Sampath Anand
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Sampath Anand. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| MASI | EVP, Ops & Clinical Research | Award / Grant | 14,593 | — | — | Feb 22, 2021 |
| MASI | EVP, Ops & Clinical Research | Tax Withholding | 786 | $268.38 | $210,947 | Jan 2, 2021 |
| MASI | EVP, Ops & Clinical Research | Option Exercise | 15,000 | $21.77 | $326,550 | Dec 15, 2020 |
| MASI | EVP, Ops & Clinical Research | Option Exercise | 19,796 | $21.77 | $430,959 | Apr 13, 2020 |
| MASI | EVP, Ops & Clinical Research | Tax Withholding | 736 | $158.58 | $116,715 | Jan 2, 2020 |
| MASI | EVP, Ops & Clinical Research | Sale | 15,000 | $155.00 | $2,325,000 | Nov 20, 2019 |
| MASI | EVP, Ops & Clinical Research | Option Exercise | 15,000 | $28.03 | $420,450 | Jun 14, 2019 |
| MASI | Chief Operating Officer | Sale | 30,000 | $115.00 | $3,450,000 | Jan 15, 2019 |
| MASI | Chief Operating Officer | Tax Withholding | 754 | $105.52 | $79,562 | Jan 2, 2019 |
| MASI | Chief Operating Officer | Sale | 30,000 | $110.00 | $3,300,000 | Nov 28, 2018 |
| MASI | Chief Operating Officer | Option Exercise | 2,000 | — | — | Feb 27, 2018 |
| MASI | Chief Operating Officer | Option Exercise | 30,000 | $30.06 | $901,800 | Jul 11, 2017 |
| MASI | Chief Operating Officer | Option Exercise | 10,000 | $14.22 | $142,200 | Jan 12, 2017 |
| MASI | Chief Operating Officer | Sale | 13,655 | $55.00 | $751,025 | Oct 31, 2016 |
| MASI | Chief Operating Officer | Sale | 15,000 | $42.00 | $630,000 | Nov 6, 2015 |